Design and Analysis of N-Of-1 Trials That Incorporate Sequential Monitoring.

Area of Science:

• Clinical Trials
• Biostatistics
• Personalized Medicine

Background:

• Patient responses to treatments vary significantly, making traditional clinical trial designs inefficient for many diseases.
• Heterogeneity in treatment response necessitates adaptive trial designs that can tailor interventions to individual patient needs.
• The N-of-1 trial, or multi-crossover randomized controlled trial, offers a personalized approach where each participant acts as their own control.

Purpose of the Study:

• To propose novel sequential monitoring designs for single-person and multi-person N-of-1 trials.
• To enable early stopping of trials once sufficient evidence of treatment preference is established for an individual or the patient group.
• To provide practical tools, including sample size calculations and decision rules, for implementing these adaptive N-of-1 designs.

Main Methods:

• Development of sequential monitoring procedures for N-of-1 trials.
• Incorporation of early stopping rules based on accumulating evidence of treatment efficacy.
• Simulation studies to evaluate the performance and properties of the proposed designs.
• Application of methods to real-world N-of-1 studies in neuro-oncology and cognitive impairment.

Main Results:

• The proposed N-of-1 designs facilitate timely identification of preferred treatments.
• Sequential monitoring allows for efficient trial conduct by enabling early termination.
• Simulation studies confirm the validity and efficiency of the developed sample size calculations and decision rules.

Conclusions:

• Novel N-of-1 trial designs with sequential monitoring enhance efficiency and personalization in clinical research.
• These adaptive designs are particularly valuable for conditions with heterogeneous patient responses, such as Alzheimer's disease.
• The proposed methods offer a robust framework for optimizing treatment selection in individual patients and patient populations.